| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
DLG1 |
IPI00218729 |
2.895 |
Evidence |
|
| VSNL1 |
VSNL1, VISL1: Visinin-like protein 1 |
CFL1 |
CFL1, CFL: Cofilin-1 |
2.895 |
Evidence |
|
| NEK3 |
NEK3: Serine/threonine-protein kinase Nek3 |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
2.895 |
Evidence |
|
| CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
2.895 |
Evidence |
|
| MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
HMGA2 |
HMGA2, HMGIC: High mobility group protein HMGI-C |
2.895 |
Evidence |
|
| MAPKAPK2 |
MAPKAPK2: MAP kinase-activated protein kinase 2 |
HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
2.895 |
Evidence |
|
| CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
2.895 |
Evidence |
O
|
| CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
2.895 |
Evidence |
|
| DDIT3 |
DDIT3, CHOP, GADD153: DNA damage-inducible transcript 3 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
2.895 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
2.895 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
SREBF2 |
IPI00478350 |
2.895 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
2.895 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
NR4A1 |
CDNA FLJ16818 fis, clone TRACH1000193, highly similar to Orphan nuclear receptor |
2.895 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
NR5A1 |
NR5A1, AD4BP, FTZF1, SF1: Steroidogenic factor 1 |
2.895 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
VCPIP1 |
VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 |
2.895 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
ABCF1 |
IPI00013495 |
2.895 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
HMGA2 |
HMGA2, HMGIC: High mobility group protein HMGI-C |
2.895 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
2.895 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
DEF6 |
DEF6, IBP: Differentially expressed in FDCP 6 |
2.895 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
2.895 |
Evidence |
|
| CD1A |
CD1A: T-cell surface glycoprotein CD1a precursor |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
2.895 |
Evidence |
|
| IL5 |
IL5: Interleukin-5 precursor |
EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
2.895 |
Evidence |
|
| SLPI |
SLPI, WAP4, WFDC4: Antileukoproteinase precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
2.895 |
Evidence |
|
| FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
2.895 |
Evidence |
|
| FGA |
IPI00021885 |
CD14 |
CD14: Monocyte differentiation antigen CD14 precursor |
2.895 |
Evidence |
|